Andreas L Norlin

Andreas L Norlin has over 20 years of experience in drug discovery and development, with a robust background in research, pre-clinical, and clinical development across academia, biotech, and big pharma. They have held significant roles such as Project Vice President at Novo Nordisk, where they led global projects in inflammatory disease and diabetes, and Chief Operating Officer at VAR2 Pharmaceuticals, focusing on new cancer therapies. Currently, they serve as a Senior Advisor at Xkout Bioscience, supporting various stakeholders in navigating drug development. Andreas has also held board positions in organizations like Malmö Montessoriskola AB and Sötrönnen AB. They earned a Ph.D. in Animal Physiology from Lund University and augmented their business acumen with executive education from prominent institutions including Copenhagen Business School and Harvard Business School.